standardised guidelines may be required to better match clinical practice with current literature cystic fibrosis cf also known as mucoviscidosis is a genetic disorder that affects mostly the lungs but also the pancreas liver kidneys and intestines major advances over the past few years in the management of cystic fibrosis cf have resulted in dramatic improvements in longevity and quality of life for many patients however respiratory dysfunction remains responsible for much of the morbidity and mortality associated with the disorder physiotherapy has long played an important role in the respiratory management of the disease and has had to adapt to the changes in disease pattern from infancy to adulthood the role of the physiotherapist is not limited to airway clearance but also includes encouragement and advice regarding exercise posture and mobility inhalation therapy and in the later stages of the disease process non invasive respiratory support it is generally felt that the use of chest physiotherapy in cf has lacked good scientific basis and the current call for evidence based medicine requires physiotherapists to scrutinize their practice closely chronic obstructive pulmonary disease copd also known as chronic obstructive lung disease cold and chronic obstructive airway disease coad among others